KRT5 and prostate cancer: Study by Trpkov et al. demonstrated that CK5/6 is an excellent and dependable basal cell marker when used in combination with AMACR; and CK 5/6 exhibited excellent specificity for prostate cancer, which uniformly lacked CK5/6 staining [5] .